Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Harmony Biosciences buys Zynerba Pharmaceuticals

8/14/23 ZYNE

Slavneft-Megionneftegaz reported for 6 months of 2023 by RAS

8/14/23 MFGS

Gazprom Neft produces an Arctic shelf of 25 million tons of oil

8/14/23 SIBN

Yuzhuralnickel reports for 6 months of 2023 by RAS

8/14/23 UNKL

Transneft plans in 2023 to pump 463 million tons of oil

8/14/23 TRNFP

Finalization of the Aurora will cost ₽300 billion

8/14/23 RTKM

Alrosa reported for 6 months of 2023 by RAS

8/14/23 ALRS

Aeroflot prepares firm contracts for the delivery of 52 Russian aircraft

8/14/23 AFLT

Beluga Group's Board of Directors recommended dividends for the first half of 2023

8/14/23 BELU

Alrosa reported for 6 months of 2023 by IFRS

8/14/23 ALRS